Product NDC: | 0186-0625 |
Proprietary Name: | PRILOSEC |
Non Proprietary Name: | Omeprazole magnesium |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Omeprazole magnesium |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0186-0625 |
Labeler Name: | AstraZeneca LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022056 |
Marketing Category: | NDA |
Start Marketing Date: | 20020209 |
Package NDC: | 0186-0625-01 |
Package Description: | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-0625-01) |
NDC Code | 0186-0625-01 |
Proprietary Name | PRILOSEC |
Package Description | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-0625-01) |
Product NDC | 0186-0625 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Omeprazole magnesium |
Dosage Form Name | GRANULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20020209 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca LP |
Substance Name | OMEPRAZOLE MAGNESIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |